In this 24th edition of BIO-Europe more than 4,000 attendees from over 60 countries participated, representing more than 2,100 companies during the three days of the event.
The Director of Business Development of VIVEbiotech, Dr. Natalia Elizalde, was present in Copenhagen and had the opportunity to meet with existing clients as well as new potential customers located around the world in need of lentiviral vectors.
VIVEbiotech is a CDMO at the service of promoters of gene therapy or cellular immunotherapy clinical trials that manufactures lentiviral vectors.